Purpose: Patient satisfaction, safety and efficacy outcomes, and cost savings with insulin pens versus conventional insulin delivery via vials and syringes in hospitalized patients with diabetes were ...
PARSIPPANY, N.J., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, today issued the following statement regarding the U.S. Food and Drug ...
Errors in insulin administration are common and can cause harm and even death. An audit aimed to standardise insulin syringe storage and labelling to improve safety Insulin is a life-saving medication ...
PROVIDENCE, R.I. (WPRI) ─ Certain lots of insulin syringes are being recalled because the graduation markings are skewed, which could cause the user to administer the wrong dose, according to the Food ...
WEST LAFAYETTE, Ind., and INDIANAPOLIS - The founder of a medical device startup based on a Purdue University innovation says his company could help people in the advanced stages of diabetes, which ...
WASHINGTON, Jan. 25 (UPI) -- The U.S. Food and Drug Administration announced the nationwide recall of all GlucoPro Insulin Syringes due to a safety hazard. The FDA said the Nipro Medical Corp. of ...
Dynarex has debuted four new products geared toward safety. The SecureSafe™ Safety Syringes have an enhanced safety mechanism and include insulin safety syringes and allergy safety syringe trays. The ...
LEWISBERRY, Pa., April 5 Unilife Corporation ("Unilife" or "Company") (Nasdaq: UNIS; ASX: UNS) today announced it has received from the U.S. Food and Drug Administration (FDA) 510(k) market clearance ...
Study design. This prospective, randomized, controlled, parallel-group study compared the use of pen devices with conventional vials and syringes for the administration of insulin in hospitalized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback